Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the The Levels and Trends of Metabolic Risk Factors in the Elderly Population at the National and Sub-National Scale in Iran From 1990 to 2016
Fatemeh Nabavizadeh Rafsanjani
Fatemeh Nabavizadeh Rafsanjani

Professor of Physiology

Department Physiology

School of Medicine

Electrophysiology Research Center

Tehran University of Medical Sciences

All Documents
1. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
2. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)